Achilles Therapeutics PLC at Chardan Genetic Medicines & Cell Therapy Manufacturing Summit (Virtual) Transcript
Hello. It's now my pleasure to introduce Dr. Iraj Ali, CEO; and Dr. Ed Samuel, EVP, Technical Operations of Achilles Therapeutics. This fireside chat will be around 25 minutes. And the audience can ask questions during the session by entering them into the question box below.
Questions & Answers
So to start off, thank you both for joining us today. Can you give us a brief overview of Achilles [PELEUS] platform and its manufacturing process?
Sure. Thanks for the invitation to talk and tell you a little bit more about Achilles. So maybe we'll just advance to the forward-looking statements. And I'd encourage people to review those in their own time. It's available on our presentation attached on our website.
But maybe if we move into the overview of Achilles, particularly for those who may be new to the story. We are targeting clonal neoantigens with patented technology and think that we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |